Regulation of obesity and lipid disorders by herbal extracts from Morus alba, Melissa officinalis, and Artemisia capillaris in high-fat diet-induced obese mice

Ayama, 1998, Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα), The Journal of Biological Chemistry, 273, 5678, 10.1074/jbc.273.10.5678 Bolkent, 2005, Protective role of Melissa officinalis L. extract on liver of hyperlipidemic rats: a morphological and biochemical study, Journal of Ethnopharmacology, 99, 391, 10.1016/j.jep.2005.02.038 Bourgeois, 1983, Dietary-induced obesity: effect of dietary fats on adipose tissue cellularity in mice, The British Journal of Nutrition, 49, 17, 10.1079/BJN19830006 Carmona, 2005, Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice, International Journal of Obesity (London), 29, 864, 10.1038/sj.ijo.0802943 Chaput, 2000, Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight, Biochemical and Biophysical Research Communications, 271, 445, 10.1006/bbrc.2000.2647 Chen, 2007, Hypolipidemic effect of flavonoids from mulberry leaves in triton WR-1339 induced hyperlipidemic mice, Asia Pacific Journal of Clinical Nutrition, 16, 290 Costet, 1998, Peroxisome proliferator-activated receptor alpha-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis, The Journal of Biological Chemistry, 273, 29577, 10.1074/jbc.273.45.29577 Das, 2006, Resveratrol in cardioprotection: a therapeutic promise of alternative medicine, Molecular Interventions, 6, 36, 10.1124/mi.6.1.7 Fruchart, 1998, Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group, The American Journal of Cardiology, 81, 912 Guerre-Millo, 2000, Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity, The Journal of Biological Chemistry, 275, 16638, 10.1074/jbc.275.22.16638 Jeong, 2007, Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen, Obesity (Silver Spring), 15, 1430, 10.1038/oby.2007.171 Jeong, 2004, Fenofibrate prevents obesity and hypertriglyceridemia in LDL receptor-null mice, Metabolism, 53, 607, 10.1016/j.metabol.2003.12.010 Jeong, 2004, Effects of fenofibrate on high fat diet-induced body weight gain and adiposity in female C57BL/6J mice, Metabolism, 53, 1284, 10.1016/j.metabol.2004.05.003 Kalderon, 1991, Tissue selective modulation of redox and phosphate potentials by beta, beta′-methyl-substituted hexadecanedioic acid, Endocrinology, 131, 1629, 10.1210/en.131.4.1629 Kersten, 2000, Roles of PPARs in health and disease, Nature, 405, 421, 10.1038/35013000 Kroetz, 1998, Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes, The Journal of Biological Chemistry, 273, 31581, 10.1074/jbc.273.47.31581 Lupien, 1991, Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins, The Canadian Journal of Cardiology, 7, 27 Mancini, 2001, Fenofibrate prevents and reduces body weight gain and adiposity in diet-induced obese rats, FEBS Letters, 491, 154, 10.1016/S0014-5793(01)02146-9 Miyahara, 2004, Inhibitory effects of mulberry leaf extract on postprandial hyperglycemia in normal rats, Journal of Nutritional Science and Vitaminology (Tokyo), 50, 161, 10.3177/jnsv.50.161 Oh, 2006, Liver PPARα and UCP2 are involved in the regulation of obesity and lipid metabolism by swim training in genetically obese db/db mice, Biochemical and Biophysical Research Communications, 345, 1232, 10.1016/j.bbrc.2006.04.182 Oku, 2006, Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity, The British Journal of Nutrition, 95, 933, 10.1079/BJN20061746 Pan, 1998, Effects of Artemisia capillaris on blood glucose and lipid in mice, Zhong Yao Cai, 21, 408 Rustan, 1992, Serum lipids, hepatic glycerolipid metabolism and peroxisomal fatty acid oxidation in rats fed omega-3 and omega-6 fatty acids, The Biochemical Journal, 283, 333, 10.1042/bj2830333 Schoonjans, 2000, Role of peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression, Journal of Lipid Research, 37, 907, 10.1016/S0022-2275(20)42003-6 Sharpe, 2007, Use of complementary and alternative medicine for weight control in the United States, Journal of Alternative and Complementary Medicine (New York, NY), 13, 217, 10.1089/acm.2006.6129 Sinal, 2001, Antagonism of the actions of peroxisome proliferator-activated receptor-α by bile acids, Journal of Biological Chemistry, 276, 47154, 10.1074/jbc.M107000200 Skrede, 1997, Thia fatty acids, metabolism and metabolic effects, Biochimica et Biophysica Acta, 1344, 115, 10.1016/S0005-2760(96)00138-5 Son, 2003, Effects of gamichunggantang on hyperlipidemia, Acta Pharmacologica Sinica, 24, 133 Staels, 1998, Mechanism of action of fibrate on lipid and lipoprotein metabolism, Circulation, 98, 2088, 10.1161/01.CIR.98.19.2088 Valcheva-Kuzmanova, 2007, Hypoglycemic and hypolipidemic effects of Aronia melanocarpa fruit juice in streptozotocin-induced diabetic rats, Methods and Findings in Experimental and Clinical Pharmacology, 29, 101, 10.1358/mf.2007.29.2.1075349 Yan, 1998, Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4, The Journal of Biological Chemistry, 273, 10948, 10.1074/jbc.273.18.10948 Yoon, 2002, Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism, Experimental and Molecular Medicine, 34, 485, 10.1038/emm.2002.67 Yoon, 2003, Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice, Biochemical and Biophysical Research Communications, 302, 29, 10.1016/S0006-291X(03)00088-3